抗α6β4整合素自身抗体抑制层粘连蛋白结合并影响胃肠道
本研究分析20例类天疱疮患者血清中的抗α6β4整合素胞外域自身抗体,发现部分患者存在该抗体,且高滴度血清可抑制层粘连蛋白-511和层粘连蛋白-332与α6β4整合素的结合,抗体滴度下降与皮肤及胃肠道症状改善相关。
要点
- 部分类天疱疮患者存在抗α6β4整合素胞外域IgG自身抗体。
- 高滴度抗α6β4整合素抗体可抑制层粘连蛋白-511和层粘连蛋白-332与α6β4整合素结合。
- 抗α6β4整合素抗体滴度下降与皮肤和胃肠道症状改善相关。
核心结论
- 部分类天疱疮患者存在抗α6β4整合素胞外域特异性自身抗体。
- 这些自身抗体对α6β4整合素与层粘连蛋白结合具有抑制活性。
- 抗α6β4整合素抗体可影响胃肠道以及皮肤和口腔黏膜。
研究设计与样本
- 用20例类天疱疮患者血清染色表达α6β4整合素胞外区的细胞以分析抗α6β4整合素自身抗体。
- 利用不同转染细胞表征抗α6β4整合素自身抗体。
- 使用表达活化构象α6β4整合素的细胞研究层粘连蛋白与α6β4整合素的结合及自身抗体的抑制作用。
- 定量分析抗体滴度与临床症状的趋势。
主要发现
- 部分类天疱疮患者存在针对α6β4整合素胞外域的IgG自身抗体。
- 在α6β4整合素活化构象下观察到层粘连蛋白与α6β4整合素结合。
- 一名高滴度抗α6β4整合素抗体患者的血清抑制层粘连蛋白-511和层粘连蛋白-332与α6β4整合素结合。
- α6β4整合素表达于皮肤和小肠基底膜,该患者表皮和小肠上皮可见剥脱。
- 抗α6β4整合素抗体滴度下降与皮肤和胃肠道症状改善相关。
临床怎么用
- 在类天疱疮患者中可检测抗α6β4整合素胞外域自身抗体。
- 抗α6β4整合素抗体滴度变化与皮肤和胃肠道症状变化相关,可用于临床观察。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anti-α6β4 integrin autoantibodies can be observed in some patients with mucous membrane pemphigoid. We have previously identified anti-α6β4 integrin extracellular domain autoantibodies together with anti-BP180 NC16A antibodies in a patient with DPP-4 inhibitor-induced bullous pemphigoid. However, the significance and impact of anti-α6β4 integrin antibodies are unknown. OBJECTIVES: To characterize anti-α6β4 integrin extracellular domain autoantibodies in pemphigoid patients, to determine whether these antibodies inhibit laminin-α6β4 integrin binding and to observe their systemic effects. METHODS: Anti-α6β4 integrin autoantibodies were analysed by staining cells expressing the extracellular region of α6β4 integrin with sera from 20 patients with pemphigoid. The anti-α6β4 integrin autoantibodies were characterized using different transfectants. The binding of laminins to α6β4 integrin was studied using cells expressing the activated conformation of α6β4 integrin and the inhibitory effect of the autoantibodies on the binding of laminins to α6β4 integrin was tested. Trends in antibody titres and clinical symptoms were quantified and analysed. RESULTS: IgG autoantibodies against the extracellular domain of anti-α6β4 integrin were found in some patients with pemphigoid. Laminin binding to α6β4 integrin was observed in the active conformation of α6β4 integrin, and serum from a patient with a high titre of anti-α6β4 integrin antibodies inhibited the binding of both laminin-511 and laminin-332 to α6β4 integrin. α6β4 integrin is expressed on the basement membrane of both skin and small intestine, and exfoliation was observed in the patient's epidermis and small intestinal epithelium. A reduction in the titre of the anti-α6β4 integrin antibody was associated with improvement in both skin and gastrointestinal symptoms. CONCLUSIONS: This study demonstrated the presence of anti-α6β4 integrin extracellular domain-specific autoantibodies in some patients with pemphigoid. In addition, these autoantibodies showed inhibitory activity on α6β4 integrin-laminin binding. Anti-α6β4 integrin antibodies can affect the gastrointestinal tract as well as the skin and oral mucosa.
引用
- Arase N, Sasaoka Y, Narita J, et al. Anti-α6β4 integrin autoantibodies inhibit the binding of laminins to α6β4 integrin in patients with pemphigoid and affect the gastrointestinal tract. J Eur Acad Dermatol Venereol. 2023. PMID: 37857595. doi:10.1111/jdv.19582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。